Trends of etiology and drug resistance in enteric fever in the last two decades in Nepal: A systematic review and meta-analysis

Clinical Infectious Diseases

Volumn 57, Issue 10, 2013, Pages

  Karki, Surendra ^a   Shakya, Prabin ^b   Cheng, Allen C ^a   Dumre, Shyam Prakash ^c   Leder, Karin ^a  

^a MONASH UNIVERSITY   (Australia)

^b Microbiological Research Organization Nepal   (Nepal)

^c National Public Health Laboratory   (Nepal)

Author keywords

Antimicrobial; Enteric fever; Paratyphoid; Resistance; Typhoid

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; NALIDIXIC ACID;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BLOOD CULTURE; EMBASE; HUMAN; MEDLINE; META ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NEPAL; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; REVIEW; SALMONELLA PARATYPHI; SALMONELLA TYPHI; SEROTYPE; SYSTEMATIC REVIEW; TYPHOID FEVER;

ANTIMICROBIAL; ENTERIC FEVER; PARATYPHOID; RESISTANCE; TYPHOID;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; NEPAL; SALMONELLA ENTERICA; SALMONELLA INFECTIONS;

EID: 84887962227     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit563     Document Type: Review

References (64)

1. Crump JA, Luby SP, Mintz ED The global burden of typhoid fever. Bull World Health Organ 2004; 82: 346-53.
2. Buckle GC, Walker CL, Black RE Typhoid fever and paratyphoid fever: Systematic review to estimate global morbidity and mortality for 2010. J Glob Health 2012; 2: 10401.
3. Lewis MD, Serichantalergs O, Pitarangsi C., et al Typhoid fever: a massive, single-point source, multidrug-resistant outbreak in Nepal. Clin Infect Dis 2005; 40: 554-61.
4. Karkey A, Arjyal A, Anders K.L., et al The burden and characteristics of enteric fever at a healthcare facility in a densely populated area of Kath-mandu. PLoS One 2010; 5: e13988.
5. Acharya D, Bhatta DR, Malla S, Dumre S.P., Adhikari N., Kandel BP Salmonella enterica serovar Paratyphi A: an emerging cause of febrile illness in Nepal. Nepal Med Coll J 2011; 13: 69-73.
6. Murdoch DR, Woods CW, Zimmerman M.D., et al The etiology of febrile illness in adults presenting to Patan hospital in Kathmandu, Nepal. Am J Trop Med Hyg 2004; 70: 670-5.
7. Maskey AP, Day JN, Phung Q.T., et al Salmonella enterica serovar Paratyphi A and S. enterica serovar Typhi cause indistinguishable clinical syndromes in Kathmandu, Nepal. Clin Infect Dis 2006; 42: 1247-53.
8. International Vaccine Institute. Summary report on Lalitpur and Bhaktapur districts school-based vaccination, 2012. Available at: http://www.ivi.int/web/ www/04-03. Accessed 14 January 2013.
9. Acharya IL, Lowe CU, Thapa R, et al Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report. N Engl J Med 1987; 317: 1101-4.
10. Woodward TE, Smadel JE, et al Preliminary report on the beneficial effect of chloromycetin in the treatment of typhoid fever. Ann Intern Med 1948; 29: 131-4.
11. Bhan MK, Bahl R, Bhatnagar S. Typhoid and paratyphoid fever. Lancet 2005; 366: 749-62.
12. Bhutta ZA. Current concepts in the diagnosis and treatment of typhoid fever. BMJ 2006; 333: 78-82.
13. Biswal N, Mathai B, Bhatia B.D., Srinivasan S., Nalini P. Enteric fever: a changing perspective. Indian Pediatr 1994; 31: 813-9.
14. Launay O, Nguyen Van JC, Buu-Hoi A, Acar JF Typhoid fever due to a Salmonella typhi strain of reduced susceptibility to fluoroquinolones. Clin Microbiol Infect 1997; 3: 541-4.
15. Parry C, Wain J, Chinh N.T., Vinh H., Farrar JJ Quinolone-resistant Salmonella typhi in Vietnam. Lancet 1998; 351: 1289.
16. Karkey A, Aryjal A, Basnyat B., Baker S. Kathmandu, Nepal: still an enteric fever capital of the world. J Infect Dev Ctries 2008; 2: 461-5.
17. National population and housing census. Central Bureau of Statistics, Government of Nepal, 2011. Available at: http://cbs.gov.np/wp-content/uploads/ 2012/11/VDC-Municipality.pdf. Accessed 23 January 2013.
18. Wolfe A. Microbial contamination in the Kathmandu Valley drinking water supply and Bagmati River: A master's thesis. submitted to. Massachusetts Institute of Technology, 2000. Available at: http://web.mit.edu/watsan/Docs/ Student%20Theses/Nepal/Wolfe2000.pdf. Accessed 23 January 2013.
19. Joshi MP, Khakurel B. Drug rationalization: now for the hard part. World Health Forum 1997; 18: 348-51.
20. Wachter DA, Joshi MP, Rimal B. Antibiotic dispensing by drug retailers in Kathmandu, Nepal. Trop Med Int Health 1999; 4: 782-8.
21. Giannakopoulos NN, Rammelsberg P, Eberhard L., Schmitter M. A new instrument for assessing the quality of studies on prevalence. Clin Oral Investig 2012; 16: 781-8.
22. Wood J. Methodology for dealing with duplicate study effects in a meta-analysis. Organizational Research Methods 2008; 11: 79-95.
23. Clinical and laboratory standard institute. Performance standards for antimicrobial susceptibility testing-first information supplement, 2011. Available at: http://www.rsu.ac.th/medtech/files/CLSI%202011.pdf. Accessed 17 July 2012.
24. Rucker G, Schwarzer G, Carpenter J., Olkin I. Why add anything to nothing? The arcsine difference as a measure of treatment effect in meta-analysis with zero cells. Stat Med 2009; 28: 721-38.
25. Miller JJ. The inverse of the Freeman-Tukey double arcsine transformation. Am Stat 1978; 32: 138.
26. Maskey AP, Basnyat B, Thwaites G.E., Campbell JI, Farrar JJ, Zimmerman MD Emerging trends in enteric fever in Nepal: 9124 cases confirmed by blood culture 1993-2003. Trans R Soc Trop Med Hyg 2008; 102: 91-5.
27. Shrestha B. Isolation of Salmonella spp. From blood and study of its antibiotic sensitivity pattern: A master's thesis. submitted to. Tribhuvan University, Kathmandu, Nepal, 1996.
28. Shakya R. Study on bacterial flora in blood specimen collected from hospitalized and out patients services of T.U. Teaching Hospital: A master's thesis. submittted to. Tribhuvan University, Kathmandu, Nepal, 2001.
29. Malla S, Kansakar P, Serichantalergs O., Rahman M, Basnet S. Epidemiology of typhoid and paratyphoid fever in Kathmandu: two years study and trends of antimicrobial resistance. J Nepal Med Assoc 2005; 44: 18-22.
30. Guha S, Jalan BY, Dey S, Easow J.M., Wilson G., Shivananda PG Salmonella bacteraemia in Pokhara: emergence of antibiotic resistance. Nepal Med Coll J 2005; 7: 23-5.
31. Sharma NP, Peacock SJ, Phumratanaprapin W, Day N., White N, Pukrittayakamee S. A hospital-based study of bloodstream infections in febrile patients in Dhulikhel Hospital Kathmandu University Teaching Hospital, Nepal. Southeast Asian J Trop Med Public Health 2006; 37: 351-6.
32. Shrestha S. Study on the prevalence of Salmonella species from blood sample of the patients visiting National Public Health Laboratory, Teku: A master's thesis. submittted to. Tribhuvan University, Kathmandu, Nepal, 2004.
33. Pokharel BM, Koirala J, Dahal R.K., Mishra SK, Khadga PK, Tuladhar NR Multidrug-resistant and extended-spectrum beta-lactamase (ESBL)-producing Salmonella enterica (serotypes Typhi and Paratyphi A) from blood isolates in Nepal: surveillance of resistance and a search for newer alternatives. Int J Infect Dis 2006; 10: 434-8.
34. Amatya NM, Shreshta B, Lekhak B. Etiological agents of bacteraemia and antibiotic susceptibility pattern of isolates in Kathmandu Model hospital, Kathmandu. J Nepal Health Res Counc 2007; 5: 5-12.
35. Khatiwada S. Study of prevalence of enteric fever and the assessment of widal test in the diagnosis of typhoid fever: A master's thesis. submitted to. Tribhuvan University, Kathmandu, Nepal, 2005.
36. Tamang MD, Oh JY, Seol S.Y., et al Emergence of multidrug-resistant Salmonella enterica serovar Typhi associated with a class 1 integron carrying the dfrA7 gene cassette in Nepal. Int J Antimicrob Agents 2007; 30: 330-5.
37. Malla S, Dumre SP Changing trend of antimicrobial resistance toward Salmonella isolates of Nepal: findings of antimicrobial resistance surveillance program, Nepal. Int J Infect Dis 2008; 12: E414-5.
38. Kelly DF, Thorson S, Maskey M., et al The burden of vaccine-preventable invasive bacterial infections and pneumonia in children admitted to hospital in urban Nepal. Int J Infect Dis 2011; 15: e17-23.
39. Kunwor R. Nalidixic acid resistant Salmonella with decreased ciprofloxacin susceptibility: A master's thesis. submitted to. Tribhuvan University, Kathmandu, Nepal, 2007.
40. Pradhan R, Shrestha U, Gautam S.C., et al Bloodstream infection among children presenting to a general hospital outpatient clinic in urban Nepal. PLoS One 2012; 7: e47531.
41. Mishra SK, Sah JP, Shrestha R, Lakhey M. Emergence of nalidixic acid resistant Salmonella: a confounding scene in antibiotic armamentarium. Journal of Nepal Association for Medical Laboratory Sciences 2008; 9: 61-4.
42. Prajapati KG. Antibiotic susceptibility pattern of salmonella from blood of suspected enteric fever patients attending Patan hospital: A master's thesis. submitted to. Tribhuvan University, Kathmandu, Nepal, 2009.
43. Aryal M. Isolation, identification and antibiotic sensitivity testing of salmonella serovars from enteric fever suspected patients visiting Bir hospital: A master's thesis. submitted to. Tribhuvan University, Kathmandu, Nepal, 2009.
44. Prajapati B, Rai GK, Rai S.K., et al Prevalence of Salmonella typhi and paratyphi infection in children: a hospital based study. Nepal Med Coll J 2008; 10: 238-41.
45. Pokharel P, Rai SK, Karki G, Katuwal A., Vitrakoti R, Shrestha SK Study of enteric fever and antibiogram of Salmonella isolates at a teaching hospital in Kathmandu Valley. Nepal Med Coll J 2009; 11: 176-8.
46. Joshi BG, Keyal K, Pandey R., Shreshta BM Clinical profile and sensitivity pattern of Salmonella serotypes in children: a hospital based study. Journal of Nepal Paediatric Society 2011; 31: 180-3.
47. Adhikari D, Acharya D, Shrestha P., Amatya R. Ciprofloxacin susceptibility of Salmonella enterica serovar Typhi and Paratyphi A from blood samples of suspected enteric fever patients. International Journal of Infection and Microbiology 2012; 1: 9-13.
48. Chaudhary R, Sijapati K, Singh SK A study on nalidixic acid resistant salmonella among the patients attending Shree Birendra Hospital. Medical Journal of Shree Birendra Hospital 2011; 10: 1-3.
49. Raza S, Tamrakar R, Bhatt C.P., Joshi SK Antimicrobial susceptibility patterns of Salmonella typhi and Salmonella paratyphi A in a tertiary care hospital. J Nepal Health Res Counc 2012; 10: 214-7.
50. Khanal B, Sharma SK, Bhattacharya S.K., Bhattarai NR, Deb M, Kanungo R. Antimicrobial susceptibility patterns of Salmonella enterica serotype typhi in eastern Nepal. J Health Popul Nutr 2007; 25: 82-7.
51. Shakya KN, Baral MR, Shrestha S. Current pattern in antimicrobial susceptibility in enteric fever in Nepali children. Post graduate Medical Journal of NAMS 2008; 8: 1-4.
52. Singh UK, Neopane AK, Thapa M, Aryal N., Agarwal K. Salmonella Typhi infections and effect of fluoroquinolones and third generation cephalosporins in clinical outcome. Journal of Nepal Paediatric Society 2011; 31: 217-21.
53. Acharya D, Malla S, Bhatta D.R., Adhikari N., Dumre SP Current fluoroquinolone susceptibility criteria for Salmonella needs re-evaluation. Kathmandu Univ Med J (KUMJ) 2012; 10: 24-9.
54. Acharya D, Trakulsomboon S, Madhup S.K., Korbsrisate S. Antibiotic susceptibility pattern and the indicator of decreased ciprofloxacin susceptibility of Salmonella enterica serovar Typhi isolated from Dhulikhel Hospital, Nepal. Jpn J Infect Dis 2012; 65: 264-7.
55. Shirakawa T, Acharya B, Kinoshita S., Kumagai S, Gotoh A, Kawabata M. Decreased susceptibility to fluoroquinolones and gyrA gene mutation in the Salmonella enterica serovar Typhi and Paratyphi A isolated in Katmandu, Nepal, in 2003. Diagn Microbiol Infect Dis 2006; 54: 299-303.
56. Vollaard AM, Ali S, van Asten HA, et al Risk factors for typhoid and paratyphoid fever in Jakarta, Indonesia. JAMA 2004; 291: 2607-15.
57. Hakanen AJ, Lindgren M, Huovinen P., Jalava J, Siitonen A, Kotilainen P. New quinolone resistance phenomenon in Salmonella enterica: nalidixic acid-susceptible isolates with reduced fluoroquinolone susceptibility. J Clin Microbiol 2005; 43: 5775-8.
58. Lindgren MM, Kotilainen P, Huovinen P., et al Reduced fluoroquinolone susceptibility in Salmonella enterica isolates from travelers, Finland. Emerg Infect Dis 2009; 15: 809-12.
59. Koirala KD, Thanh DP, Thapa S.D., et al Highly resistant Salmonella enterica serovar Typhi with a novel gyrA mutation raises questions about the long-term efficacy of older fluoroquinolones for treating typhoid fever. Antimicrob Agents Chemother 2012; 56: 2761-2.
60. Nath G, Maurya P. Drug resistance patterns in Salmonella enterica subspecies enterica serotype Typhi strains isolated over a period of two decades, with special reference to ciprofloxacin and ceftriaxone. Int J Antimicrob Agents 2010; 35: 482-5.
61. Indian Network for Surveillance of Antimicrobial Resistance Group. Antibiogram of S. enterica serovar Typhi and S. enterica serovar Paratyphi A: a multi-centre study from India. WHO South-East Asia Journal of Public Health 2012; 1: 182-8.
62. Dutta S, Sur D, Manna B., Bhattacharya SK, Deen JL, Clemens JD Rollback of Salmonella enterica serotype Typhi resistance to chloramphenicol and other antimicrobials in Kolkata, India. Antimicrob Agents Chemother 2005; 49: 1662-3.
63. Pandit A, Arjyal A, Day J.N., et al An open randomized comparison of gatifloxacin versus cefixime for the treatment of uncomplicated enteric fever. PLoS ONE 2007; 2: e542.
64. Butler T. Treatment of typhoid fever in the 21st century: promises and shortcomings. Clinical Microbiology and Infection 2011; 17: 959-63.